BIO vs VNO · rev $651.0M vs rev $921.3M
BIO (BIO) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
VNO (VNO) common stock.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
BIO currently screens at market cap $0. VNO currently screens at market cap $0.
Not investment advice. Open the BIO and VNO stock pages for the full models.
Not investment advice.